Unique delivery Leverage OncoImmunin’s patented delivery technology for peptides and oligonucleotides to position as a specialized partner for companies seeking improved intracellular delivery and targeted therapeutics, highlighting potential collaborations in drug delivery platforms.

Small team With a lean team alignment, offer scalable partnership models such as co-development, contract research, and milestone-based programs that align with limited internal resources while enabling rapid collaboration and decision cycles.

Emerging revenue Target mid-market biotechs and early-stage pharma aiming to accelerate clinical timelines; emphasize rapid value realization through proof-of-concept studies and enabling technologies that can de-risk pipeline progression.

Tech stack Highlight compatibility with standard biotech workflows and web-enabled collaboration; propose cloud-based data sharing, secure project portals, and integrated communication to streamline joint research efforts.

Growth fit Position as a strategic partner for larger biotechs in need of niche delivery expertise to complement in-house R&D, with a focus on potential acquisitions or license deals once feasibility is demonstrated.